These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15552778)

  • 1. Using molecular markers in sputum for the early detection of lung cancer: a review.
    Kennedy TC; Hirsch FR
    Lung Cancer; 2004 Aug; 45 Suppl 2():S21-7. PubMed ID: 15552778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnostic markers for lung cancer in sputum and plasma.
    Wang YC; Hsu HS; Chen TP; Chen JT
    Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection.
    Gomperts BN; Spira A; Elashoff DE; Dubinett SM
    Cancer Prev Res (Phila); 2010 Apr; 3(4):420-3. PubMed ID: 20332300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of tumor markers in lung cancer.
    Strauss GM; Skarin AT
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):507-32. PubMed ID: 8707770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
    Kennedy TC; Franklin WA; Prindiville SA; Cook R; Dempsey EC; Keith RL; Hirsch FR; Merrick TA; Shroyer KR; Petty TL; Byers T; Bunn PA; Miller YE
    Lung Cancer; 2005 Aug; 49(2):187-91. PubMed ID: 16022912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-promoter hypermethylation as a biomarker in lung cancer.
    Belinsky SA
    Nat Rev Cancer; 2004 Sep; 4(9):707-17. PubMed ID: 15343277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
    Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
    Cho WC
    Biomed Pharmacother; 2007 Oct; 61(9):515-9. PubMed ID: 17913444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
    Belinsky SA; Liechty KC; Gentry FD; Wolf HJ; Rogers J; Vu K; Haney J; Kennedy TC; Hirsch FR; Miller Y; Franklin WA; Herman JG; Baylin SB; Bunn PA; Byers T
    Cancer Res; 2006 Mar; 66(6):3338-44. PubMed ID: 16540689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for lung cancer: clinical uses.
    Greenberg AK; Lee MS
    Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
    Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway.
    Lam B; Lam SY; Wong MP; Ooi CG; Fong DY; Lam DC; Lai AY; Tam CM; Pang CB; Ip MS; Lam WK
    Lung Cancer; 2009 Jun; 64(3):289-94. PubMed ID: 19010567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular biology of lung cancer: application to early detection and prevention.
    Sabichi AL; Birrer MJ
    Oncology (Williston Park); 1993 Jun; 7(6):19-26; discussion 31-2, 37. PubMed ID: 8318356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on screening for lung cancer.
    Midthun DE; Jett JR
    Semin Respir Crit Care Med; 2008 Jun; 29(3):233-40. PubMed ID: 18506661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and early detection of lung cancer.
    Van't Westeinde SC; van Klaveren RJ
    Cancer J; 2011; 17(1):3-10. PubMed ID: 21263260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.